Ben Ho Park Archive
-
August 11, 2022
Cell-free breast cancer “biopsy”
The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer. -
February 17, 2022
Park named director of Vanderbilt-Ingram Cancer Center
Ben Ho Park, MD, PhD, deputy director of the Vanderbilt-Ingram Cancer Center, has been named the center’s new director. -
August 19, 2021
Park named to new role as deputy director of Vanderbilt-Ingram Cancer Center
Ben Ho Park, MD, PhD, Cornelius Abernathy Professor of Medicine, has been named deputy director of Vanderbilt-Ingram Cancer Center (VICC). -
October 21, 2020
Park named director of Hematology and Oncology at VICC
After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, Donna S. Hall Professor of Breast Cancer Research at Vanderbilt University Medical Center, has been named director of the Division of Hematology and Oncology. -
January 9, 2020
Park named interim Hematology and Oncology director
Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology. -
September 5, 2019
Study backs genetic testing for all metastatic breast cancer patients
-
May 17, 2018
Park named to VICC breast cancer leadership position